Literature DB >> 29970492

Complication free survival long-term after hemopoietic cell transplantation in thalassemia.

Emanuele Angelucci1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29970492      PMCID： PMC6029536          DOI： 10.3324/haematol.2018.196071

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

Review 1.  Hematopoietic stem cell transplantation in thalassemia.

Authors:  Emanuele Angelucci
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

2.  Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later.

Authors:  Emanuele Angelucci; Federica Pilo; Thomas D Coates
Journal:  Am J Hematol       Date:  2017-03-22       Impact factor: 10.047

3.  Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.

Authors:  Giorgio La Nasa; Giovanni Caocci; Fabio Efficace; Carlo Dessì; Adriana Vacca; Eugenia Piras; Marco Sanna; Michela Marcias; Roberto Littera; Carlo Carcassi; Guido Lucarelli
Journal:  Blood       Date:  2013-08-19       Impact factor: 22.113

4.  Pregnancy outcome following hematopoietic cell transplantation for thalassemia major.

Authors:  S Santarone; A Natale; P Olioso; D Onofrillo; C D'Incecco; G Parruti; P Di Bartolomeo
Journal:  Bone Marrow Transplant       Date:  2016-11-07       Impact factor: 5.483

5.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Authors:  Caterina Borgna-Pignatti; Simone Rugolotto; Piero De Stefano; Huaqing Zhao; Maria Domenica Cappellini; Giovanni Carlo Del Vecchio; Maria Antonietta Romeo; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Avital Cnaan
Journal:  Haematologica       Date:  2004-10       Impact factor: 9.941

Review 6.  Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?

Authors:  Thomas D Coates; Susan Carson; John C Wood; Vasilios Berdoukas
Journal:  Ann N Y Acad Sci       Date:  2016-03       Impact factor: 5.691

Review 7.  Management of iron overload before, during, and after hematopoietic stem cell transplantation for thalassemia major.

Authors:  Emanuele Angelucci; Federica Pilo
Journal:  Ann N Y Acad Sci       Date:  2016-03-21       Impact factor: 5.691

8.  Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major.

Authors:  S Santarone; A Pepe; A Meloni; A Natale; L Pistoia; P Olioso; G Papalinetti; L Cuccia; A Spasiano; R Lisi; M Di Ianni; T Bonfini; P Accorsi; S Salvadori; F Papola; S Angelini; P Di Bartolomeo
Journal:  Bone Marrow Transplant       Date:  2017-10-09       Impact factor: 5.483

9.  Marrow transplantation for patients with thalassemia: results in class 3 patients.

Authors:  G Lucarelli; R A Clift; M Galimberti; P Polchi; E Angelucci; D Baronciani; C Giardini; M Andreani; M Manna; S Nesci; F Agostinelli; S Rapa; M Ripalti; F Albertini
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

10.  Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.

Authors:  Ilhem Rahal; Claire Galambrun; Yves Bertrand; Nathalie Garnier; Catherine Paillard; Pierre Frange; Corinne Pondarré; Jean Hugues Dalle; Regis Peffault de Latour; Mauricette Michallet; Dominique Steschenko; Despina Moshous; Patrick Lutz; Jean Louis Stephan; Pierre Simon Rohrlich; Ibrahim Yakoub-Agha; Françoise Bernaudin; Christophe Piguet; Nathalie Aladjidi; Catherine Badens; Claire Berger; Gérard Socié; Cécile Dumesnil; Marie Pierre Castex; Marilyne Poirée; Anne Lambilliotte; Caroline Thomas; Pauline Simon; Pascal Auquier; Gérard Michel; Anderson Loundou; Imane Agouti; Isabelle Thuret
Journal:  Haematologica       Date:  2018-03-29       Impact factor: 9.941
View more
  5 in total

1.  Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche.

Authors:  Annamaria Aprile; Alessandro Gulino; Mariangela Storto; Isabella Villa; Stefano Beretta; Ivan Merelli; Alessandro Rubinacci; Maurilio Ponzoni; Sarah Marktel; Claudio Tripodo; Maria Rosa Lidonnici; Giuliana Ferrari
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

Review 2.  HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe.

Authors:  Christina Oikonomopoulou; Evgenios Goussetis
Journal:  Bone Marrow Transplant       Date:  2021-09-16       Impact factor: 5.483

Review 3.  Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.

Authors:  Annamaria Aprile; Silvia Sighinolfi; Laura Raggi; Giuliana Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-11

Review 4.  Advancing the care of β-thalassaemia patients with novel therapies.

Authors:  Rayan Bou-Fakhredin; Irene Motta; Maria Domenica Cappellini
Journal:  Blood Transfus       Date:  2021-10-21       Impact factor: 3.443

5.  Challenging the Erythropoiesis Paradigm in β-Thalassemia.

Authors:  Francesca Vinchi; Steven Zebulon Vance
Journal:  Hemasphere       Date:  2020-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.